Substance list · California

Suggested substance list

Entries
1015
Version date
2026-07-31

Entries 1 to 500 of 1015

SubstanceEnglish nameCAS TypeCategoryThreshold ConditionsValid
A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)A-alpha-C (2-Amino-9H-pyrido[2,3-b]indole)26148-68-5 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Abiraterone acetateAbiraterone acetate154229-18-2 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2016-04-08
AcetaldehydeAcetaldehyde75-07-0 substancecancer 90 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
AcetamideAcetamide60-35-5 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
AcetazolamideAcetazolamide59-66-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
AcetochlorAcetochlor34256-82-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Acetohydroxamic acidAcetohydroxamic acid546-88-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
2-Acetylaminofluorene2-Acetylaminofluorene53-96-3 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Acifluorfen sodiumAcifluorfen sodium62476-59-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
AcrylamideAcrylamide79-06-1 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
AcrylamideAcrylamide79-06-1 substancedevelopmental, male 140 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-02-25
AcrylonitrileAcrylonitrile107-13-1 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
Actinomycin D [Basis for listing changed effective February 22, 2013]Actinomycin D [Basis for listing changed effective February 22, 2013]50-76-0 substancecancer 0.00008 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1989-10-01
Actinomycin DActinomycin D50-76-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
AF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamideAF-2;[2-(2-furyl)-3-(5-nitro-2-furyl)]acrylamide3688-53-7 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
AflatoxinsAflatoxins othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01 | CAS column: "---"
AlachlorAlachlor15972-60-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Alcoholic beveragesAlcoholic beverages othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-04-29 | CAS column: "---"
Alcoholic beverages, when associated with alcohol abuseAlcoholic beverages, when associated with alcohol abuse othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01 | CAS column: "---"
AldrinAldrin309-00-2 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01
All-trans retinoic acidAll-trans retinoic acid302-79-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Allyl chlorideAllyl chloride107-05-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | Delisted: October 29, 1999 until 1999-10-29
Aloe vera, non-decolorized whole leaf extractAloe vera, non-decolorized whole leaf extract othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2015-12-04 | CAS column: "---"
AlprazolamAlprazolam28981-97-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
AltretamineAltretamine645-05-6 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
Amantadine hydrochlorideAmantadine hydrochloride665-66-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
Amikacin sulfateAmikacin sulfate39831-55-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
2-Aminoanthraquinone2-Aminoanthraquinone117-79-3 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
p-Aminoazobenzenep-Aminoazobenzene60-09-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
o-Aminoazotolueneo-Aminoazotoluene97-56-3 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
4-Aminobiphenyl (4-aminodiphenyl)4-Aminobiphenyl (4-aminodiphenyl)92-67-1 substancecancer 0.03 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
2-Amino-4-chlorophenol2-Amino-4-chlorophenol95-85-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
1-Amino-2,4-dibromoanthraquinone1-Amino-2,4-dibromoanthraquinone81-49-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
3-Amino-9-ethylcarbazole hydrochloride3-Amino-9-ethylcarbazole hydrochloride6109-97-3 substancecancer 9 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
2-Aminofluorene2-Aminofluorene153-78-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-01-29
AminoglutethimideAminoglutethimide125-84-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
AminoglycosidesAminoglycosides otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
1-Amino-2-methylanthraquinone1-Amino-2-methylanthraquinone82-28-0 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole712-68-5 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
4-Amino-2-nitrophenol4-Amino-2-nitrophenol119-34-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-01-29
AminopterinAminopterin54-62-6 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Amiodarone hydrochlorideAmiodarone hydrochloride19774-82-4 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
AmitrazAmitraz33089-61-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
AmitroleAmitrole61-82-5 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
AmoxapineAmoxapine14028-44-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
AmsacrineAmsacrine51264-14-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07
tert-Amyl methyl ethertert-Amyl methyl ether994-05-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-12-18 | Delisted: December 13, 2013 until 2013-12-13
Anabolic steroidsAnabolic steroids otherfemale, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01 | CAS column: "---"
Analgesic mixtures containing PhenacetinAnalgesic mixtures containing Phenacetin groupcancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
AndrostenedioneAndrostenedione63-05-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-05-03
Angiotensin converting enzyme (ACE) inhibitorsAngiotensin converting enzyme (ACE) inhibitors otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
AnilineAniline62-53-3 substancecancer 100 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Aniline hydrochlorideAniline hydrochloride142-04-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
o-Anisidineo-Anisidine90-04-0 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
o-Anisidine hydrochlorideo-Anisidine hydrochloride134-29-2 substancecancer 7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
AnisindioneAnisindione117-37-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
AnthraceneAnthracene120-12-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-08-11
AnthraquinoneAnthraquinone84-65-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2007-09-28
Antimony oxide (Antimony trioxide)Antimony oxide (Antimony trioxide)1309-64-4 substancecancer 0.13 (inhalation) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
AramiteAramite140-57-8 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Areca nutAreca nut othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2006-02-03 | CAS column: "---"
Aristolochic acidsAristolochic acids othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2004-07-09 | CAS column: "---"
Arsenic (inorganic arsenic compounds)Arsenic (inorganic arsenic compounds) groupcancer 0.06 (inhalation) 10 (except inhalation) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "--"
Arsenic (inorganic oxides)Arsenic (inorganic oxides) otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-05-01 | CAS column: "---"
AsbestosAsbestos1332-21-4 substancecancer 100 fibers/day (inhalation) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Aspirin (NOTE: It is especially important not to use aspirin during the last three months of pregnancy, unless specifically directed to do so by a physician because it may cause problems in the unborn child or complications during delivery.)Aspirin (NOTE: It is especially important not to use aspirin during the last three months of pregnancy, unless specifically directed to do so by a physician because it may cause problems in the unborn child or complications during delivery.)50-78-2 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1990-07-01
AtenololAtenolol29122-68-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
AtrazineAtrazine1912-24-9 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
AuramineAuramine492-80-8 substancecancer 0.8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
AuranofinAuranofin34031-32-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Avermectin B1 (Abamectin)Avermectin B1 (Abamectin)71751-41-2 substancedevelopmental 4.4 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-12-03
AzacitidineAzacitidine320-67-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-01-01
AzaserineAzaserine115-02-6 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
AzathioprineAzathioprine446-86-6 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
AzathioprineAzathioprine446-86-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
AzobenzeneAzobenzene103-33-3 substancecancer 6 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
BarbituratesBarbiturates otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
Beclomethasone dipropionateBeclomethasone dipropionate5534-09-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
BenomylBenomyl17804-35-2 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1991-07-01
Benthiavalicarb-isopropylBenthiavalicarb-isopropyl177406-68-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-07-01
Benz[a]anthraceneBenz[a]anthracene56-55-3 substancecancer 0.033 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
BenzeneBenzene71-43-2 substancecancer 6.4 (oral) 13 (inhalation) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
BenzeneBenzene71-43-2 substancedevelopmental, male 24 (oral) 49 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-12-26
Benzidine [and its salts]Benzidine [and its salts]92-87-5 substancecancer 0.001 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Benzidine-based dyesBenzidine-based dyes othercancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
BenzodiazepinesBenzodiazepines otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01 | CAS column: "---"
Benzo[b]fluorantheneBenzo[b]fluoranthene205-99-2 substancecancer 0.096 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Benzo[j]fluorantheneBenzo[j]fluoranthene205-82-3 substancecancer 0.11 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Benzo[k]fluorantheneBenzo[k]fluoranthene207-08-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
BenzofuranBenzofuran271-89-6 substancecancer 1.1 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
BenzophenoneBenzophenone119-61-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-06-22
Benzo[a]pyreneBenzo[a]pyrene50-32-8 substancecancer 0.06 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
BenzotrichlorideBenzotrichloride98-07-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Benzphetamine hydrochlorideBenzphetamine hydrochloride5411-22-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Benzyl chlorideBenzyl chloride100-44-7 substancecancer 4 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Benzyl violet 4BBenzyl violet 4B1694-09-3 substancecancer 30 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Beryllium and beryllium compoundsBeryllium and beryllium compounds groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---"
BerylliumBeryllium othercancer 0.1 µg/day (NSRL or MADL) Sub entry under "Beryllium and beryllium compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Beryllium oxideBeryllium oxide othercancer 0.1 µg/day (NSRL or MADL) Sub entry under "Beryllium and beryllium compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Beryllium sulfateBeryllium sulfate othercancer 0.0002 µg/day (NSRL or MADL) Sub entry under "Beryllium and beryllium compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Betel quid with tobaccoBetel quid with tobacco othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | CAS column: "---"
Betel quid without tobaccoBetel quid without tobacco othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2006-02-03 | CAS column: "---"
BevacizumabBevacizumab216974-75-3 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2019-03-08
2,2-Bis(bromomethyl)-1,3-propanediol2,2-Bis(bromomethyl)-1,3-propanediol3296-90-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
Bis(2-chloroethyl)etherBis(2-chloroethyl)ether111-44-4 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
N,N-Bis(2-chloroethyl)-2-naphthylamine (Chlornapazine)N,N-Bis(2-chloroethyl)-2-naphthylamine (Chlornapazine)494-03-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Bischloroethyl nitrosourea (BCNU) (Carmustine)Bischloroethyl nitrosourea (BCNU) (Carmustine)154-93-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Bischloroethyl nitrosourea (BCNU) (Carmustine)Bischloroethyl nitrosourea (BCNU) (Carmustine)154-93-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Bis(chloromethyl)etherBis(chloromethyl)ether542-88-1 substancecancer 0.02 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Bis(2-chloro-1-methylethyl)ether, technical gradeBis(2-chloro-1-methylethyl)ether, technical grade othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-10-29 | CAS column: "---"
Bisphenol A (BPA)Bisphenol A (BPA)80-05-7 substancefemale 3 (dermal exposure from solid materials) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2015-05-11
Bisphenol A (BPA)Bisphenol A (BPA)80-05-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2020-12-18
Bisphenol S (BPS)Bisphenol S (BPS)80-09-1 substancefemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2023-12-29
Bisphenol S (BPS)Bisphenol S (BPS)80-09-1 substancemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2025-01-03
Bisphenol S (BPS)Bisphenol S (BPS)80-09-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2025-12-08
Bitumens, extracts of steam-refined and air refinedBitumens, extracts of steam-refined and air refined othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | CAS column: "---"
Bracken fernBracken fern othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | CAS column: "---"
Bromacil lithium saltBromacil lithium salt53404-19-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-05-18
Bromacil lithium saltBromacil lithium salt53404-19-6 substancemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2003-01-17
BromateBromate15541-45-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2002-05-31
Bromochloroacetic acidBromochloroacetic acid5589-96-8 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-04-06
1-Bromo-3-chloropropane1-Bromo-3-chloropropane109-70-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-01-27
Bromodichloroacetic acidBromodichloroacetic acid71133-14-7 substancecancer 0.95 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-29
BromodichloromethaneBromodichloromethane75-27-4 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
BromoethaneBromoethane74-96-4 substancecancer 96 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-12-22
BromoformBromoform75-25-2 substancecancer 64 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1991-04-01
1-Bromopropane (1-BP)1-Bromopropane (1-BP)106-94-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-08-05
1-Bromopropane (1-BP)1-Bromopropane (1-BP)106-94-5 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-12-07
2-Bromopropane (2-BP)2-Bromopropane (2-BP)75-26-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-08-11
2-Bromopropane (2-BP)2-Bromopropane (2-BP)75-26-3 substancefemale, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-05-31
BromoxynilBromoxynil1689-84-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-10-01
Bromoxynil octanoateBromoxynil octanoate1689-99-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-05-18
Butabarbital sodiumButabarbital sodium143-81-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
1,3-Butadiene1,3-Butadiene106-99-0 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
1,3-Butadiene1,3-Butadiene106-99-0 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-04-16
1,4-Butanediol dimethanesulfonate (Busulfan)1,4-Butanediol dimethanesulfonate (Busulfan)55-98-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
1,4-Butanediol dimethanesulfonate (Busulfan)1,4-Butanediol dimethanesulfonate (Busulfan)55-98-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Butylated hydroxyanisoleButylated hydroxyanisole25013-16-5 substancecancer 4000 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Butyl benzyl phthalate (BBP)dButyl benzyl phthalate (BBP)d85-68-7 substancedevelopmental 1200 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-12-02
1-Butyl glycidyl ether1-Butyl glycidyl ether2426-08-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-01-27
n-Butyl glycidyl ethern-Butyl glycidyl ether2426-08-6 substancemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: April 4, 2014 until 2014-04-04
beta-Butyrolactonebeta-Butyrolactone3068-88-0 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Cacodylic acidCacodylic acid75-60-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
CadmiumCadmium otherdevelopmental, male 4.1 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-05-01 | CAS column: "---"
Cadmium and cadmium compoundsCadmium and cadmium compounds groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---"
CadmiumCadmium othercancer 0.05 (inhalation) µg/day (NSRL or MADL) Sub entry under "Cadmium and cadmium compounds" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
Cannabis (marijuana) smokeCannabis (marijuana) smoke otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2020-01-03 | CAS column: "---"
Caffeic acidCaffeic acid331-39-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
CaptafolCaptafol2425-06-1 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
CaptanCaptan133-06-2 substancecancer 300 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
CarbamazepineCarbamazepine298-46-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
CarbarylCarbaryl63-25-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-02-05
Carbaryl [Basis for listing changed effective December 27, 2013]Carbaryl [Basis for listing changed effective December 27, 2013]63-25-2 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2009-08-07
CarbazoleCarbazole86-74-8 substancecancer 4.1 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
Carbon black (airborne, unbound particles of respirable size)Carbon black (airborne, unbound particles of respirable size)1333-86-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2003-02-21
Carbon-black extractsCarbon-black extracts othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | CAS column: "---"
Carbon disulfideCarbon disulfide75-15-0 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Carbon monoxideCarbon monoxide630-08-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Carbon tetrachlorideCarbon tetrachloride56-23-5 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
CarboplatinCarboplatin41575-94-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
N-Carboxymethyl-N-nitrosoureaN-Carboxymethyl-N-nitrosourea60391-92-6 substancecancer 0.7 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2002-01-25
CatecholCatechol120-80-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2003-07-15
Ceramic fibers (airborne particles of respirable size)Ceramic fibers (airborne particles of respirable size) othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01 | CAS column: "---"
Certain combined chemotherapy for lymphomasCertain combined chemotherapy for lymphomas othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
ChenodiolChenodiol474-25-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
ChloralChloral75-87-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2013-09-13
Chloral hydrateChloral hydrate302-17-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2013-09-13
ChlorambucilChlorambucil305-03-3 substancecancer 0.002 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
ChlorambucilChlorambucil305-03-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
ChloramphenicolChloramphenicol56-75-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01 | Delisted: January 4, 2013 until 2013-01-04
Chloramphenicol sodium succinateChloramphenicol sodium succinate982-57-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2013-09-27
Chlorcyclizine hydrochlorideChlorcyclizine hydrochloride1620-21-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
ChlordaneChlordane57-74-9 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01
Chlordecone (Kepone)Chlordecone (Kepone)143-50-0 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Chlordecone (Kepone)Chlordecone (Kepone)143-50-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
ChlordiazepoxideChlordiazepoxide58-25-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
Chlordiazepoxide hydrochlorideChlordiazepoxide hydrochloride438-41-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
ChlordimeformChlordimeform6164-98-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Chlorendic acidChlorendic acid115-28-6 substancecancer 8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Chlorinated paraffins (Average chain length, C12;approximately 60 percent chlorine by weight)Chlorinated paraffins (Average chain length, C12;approximately 60 percent chlorine by weight)108171-26-2 substancecancer 8 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
p-Chloroanilinep-Chloroaniline106-47-8 substancecancer 1.5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
p-Chloroaniline hydrochloridep-Chloroaniline hydrochloride20265-96-7 substancecancer 1.9 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
ChlorodibromomethaneChlorodibromomethane124-48-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | Delisted: October 29, 1999 until 1999-10-29
Chloroethane (Ethyl chloride)Chloroethane (Ethyl chloride)75-00-3 substancecancer 150 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine)1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine)13010-47-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine)1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine)13010-47-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU)1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU)13909-09-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
ChloroformChloroform67-66-3 substancecancer 20 (oral) 40 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
Chloroform [Basis for listing changed effective December 23, 2016]Chloroform [Basis for listing changed effective December 23, 2016]67-66-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2009-08-07
Chloromethyl methyl ether (technical grade)Chloromethyl methyl ether (technical grade)107-30-2 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
3-Chloro-2-methylpropene3-Chloro-2-methylpropene563-47-3 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
1-Chloro-4-nitrobenzene1-Chloro-4-nitrobenzene100-00-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-10-29
2-Chloronitrobenzene2-Chloronitrobenzene88-73-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
4-Chloro-o-phenylenediamine4-Chloro-o-phenylenediamine95-83-0 substancecancer 40 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
ChloropreneChloroprene126-99-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-06-02
2-Chloropropionic acid [Basis for listing changed effective December 20, 2013]2-Chloropropionic acid [Basis for listing changed effective December 20, 2013]598-78-7 substancemale µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2009-08-07
ChlorothalonilChlorothalonil1897-45-6 substancecancer 41 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
p-Chloro-o-toluidinep-Chloro-o-toluidine95-69-2 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
p-Chloro-o-toluidine, strong acid salts ofp-Chloro-o-toluidine, strong acid salts of groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15 | CAS column: "---"
p-Chloro-o-toluidine, hydrochloridep-Chloro-o-toluidine, hydrochloride othercancer 3.3 µg/day (NSRL or MADL) Sub entry under "p-Chloro-o-toluidine, strong acid salts of" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry
5-Chloro-o-toluidine and its strong acid salts5-Chloro-o-toluidine and its strong acid salts groupcancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1997-10-24 | CAS column: "---"
ChlorotrianiseneChlorotrianisene569-57-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
p-chloro-α,α,α-trifluorotoluene (para-Chlorobenzotrifluoride, PCBTF)p-chloro-α,α,α-trifluorotoluene (para-Chlorobenzotrifluoride, PCBTF)98-56-6 substancecancer 23 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2019-06-28
ChlorozotocinChlorozotocin54749-90-5 substancecancer 0.003 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-01-01
ChlorpyrifosChlorpyrifos2921-88-2 substancedevelopmental 0.58 (oral and inhalation) 7.2 (dermal) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2017-12-15
ChlorsulfuronChlorsulfuron64902-72-3 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-05-14 | Delisted: June 6, 2014 until 2014-06-06
Chromium (hexavalent compounds)Chromium (hexavalent compounds) groupcancer 0.001 (inhalation) µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
Chromium (hexavalent compounds)Chromium (hexavalent compounds) groupdevelopmental, female, male 8.2 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2008-12-19 | CAS column: "---"
ChryseneChrysene218-01-9 substancecancer 0.35 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
C.I. Acid Red 114C.I. Acid Red 1146459-94-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01
C.I. Basic Red 9 monohydrochlorideC.I. Basic Red 9 monohydrochloride569-61-9 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
C.I. Direct Blue 15C.I. Direct Blue 152429-74-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
C.I. Direct Blue 218C.I. Direct Blue 21828407-37-6 substancecancer 50 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
C.I. Disperse Yellow 3C.I. Disperse Yellow 32832-40-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2013-02-08
C.I. Solvent Yellow 14C.I. Solvent Yellow 14842-07-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Ciclosporin (Cyclosporin A; Cyclosporine)Ciclosporin (Cyclosporin A; Cyclosporine)59865-13-3; 79217-60-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-01-01
CidofovirCidofovir113852-37-2 substancecancer, developmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Cinnamyl anthranilateCinnamyl anthranilate87-29-6 substancecancer 200 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
CisplatinCisplatin15663-27-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
Citrus Red No. 2Citrus Red No. 26358-53-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
CladribineCladribine4291-63-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
ClarithromycinClarithromycin81103-11-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
Clobetasol propionateClobetasol propionate25122-46-7 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
ClofibrateClofibrate637-07-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
Clomiphene citrateClomiphene citrate50-41-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2013-05-24
Clomiphene citrateClomiphene citrate50-41-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Clorazepate dipotassiumClorazepate dipotassium57109-90-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
CMNP (pyrazachlor)CMNP (pyrazachlor)6814-58-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2015-08-25
Coal-tar pitchCoal-tar pitch othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-11-17 | CAS column: "---"
Cobalt metal powderCobalt metal powder7440-48-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01
Cobalt [II] oxideCobalt [II] oxide1307-96-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-07-01
Cobalt sulfateCobalt sulfate10124-43-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2005-05-20
Cobalt sulfate heptahydrateCobalt sulfate heptahydrate10026-24-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-06-02
CocaineCocaine50-36-2 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Coconut oil diethanolamine condensate (cocamide diethanolamine)Coconut oil diethanolamine condensate (cocamide diethanolamine) othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-06-22 | CAS column: "---"
Codeine phosphateCodeine phosphate52-28-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
Coke oven emissionsCoke oven emissions othercancer 0.3 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
ColchicineColchicine64-86-8 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
Conjugated estrogensConjugated estrogens othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27 | CAS column: "---"
Conjugated estrogensConjugated estrogens otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01 | CAS column: "---"
CreosotesCreosotes othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01 | CAS column: "---"
p-Cresidinep-Cresidine120-71-8 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
CumeneCumene98-82-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-04-06
CupferronCupferron135-20-6 substancecancer 3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
CyanazineCyanazine21725-46-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
CycasinCycasin14901-08-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
CycloateCycloate1134-23-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-19
CyclohexanolCyclohexanol108-93-0 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06 | Delisted: January 25, 2002 until 2002-01-25
CycloheximideCycloheximide66-81-9 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1989-01-01
Cyclopenta[cd]pyreneCyclopenta[cd]pyrene27208-37-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-04-29
Cyclophosphamide (anhydrous)Cyclophosphamide (anhydrous)50-18-0 substancecancer 1 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Cyclophosphamide (anhydrous)Cyclophosphamide (anhydrous)50-18-0 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: SQE - developmental FR - female, male; Date listed: 1989-01-01
Cyclophosphamide (hydrated)Cyclophosphamide (hydrated)6055-19-2 substancecancer 1 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Cyclophosphamide (hydrated)Cyclophosphamide (hydrated)6055-19-2 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: SQE - developmental FR - female, male; Date listed: 1989-01-01
CyhexatinCyhexatin13121-70-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1989-01-01
CytarabineCytarabine147-94-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
CytembenaCytembena21739-91-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
D&C Orange No. 17D&C Orange No. 173468-63-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
D&C Red No. 8D&C Red No. 82092-56-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
D&C Red No. 9D&C Red No. 95160-02-1 substancecancer 100 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
D&C Red No. 19D&C Red No. 1981-88-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
DacarbazineDacarbazine4342-03-4 substancecancer 0.01 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
DacarbazineDacarbazine4342-03-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
DaminozideDaminozide1596-84-5 substancecancer 40 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
DanazolDanazol17230-88-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone)117-10-2 substancecancer 9 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-01-01
DaunomycinDaunomycin20830-81-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Daunorubicin hydrochlorideDaunorubicin hydrochloride23541-50-6 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
2,4-D butyric acid [Click here for the basis for the removal of developmental endpoint, effective June 22, 2001]2,4-D butyric acid [Click here for the basis for the removal of developmental endpoint, effective June 22, 2001]94-82-6 substancedevelopmental, male 910 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-06-18
DDD (Dichlorodiphenyl-dichloroethane)DDD (Dichlorodiphenyl-dichloroethane)72-54-8 substancecancer 2 (DDT, DDE, DDD in combination) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
DDE (Dichlorodiphenyl-dichloroethylene)DDE (Dichlorodiphenyl-dichloroethylene)72-55-9 substancecancer 2 (DDT, DDE, DDD in combination) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
DDT (Dichlorodiphenyl-trichloroethane)DDT (Dichlorodiphenyl-trichloroethane)50-29-3 substancecancer 2 (DDT, DDE, DDD in combination) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
o,p'-DDTo,p'-DDT789-02-6 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
p,p'-DDTp,p'-DDT50-29-3 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
DDVP (Dichlorvos)DDVP (Dichlorvos)62-73-7 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Demeclocycline hydrochloride (internal use)Demeclocycline hydrochloride (internal use)64-73-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
Des-ethyl atrazine (DEA)Des-ethyl atrazine (DEA)6190-65-4 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
Des-isopropyl atrazine (DIA)Des-isopropyl atrazine (DIA)1007-28-9 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
N,N'-DiacetylbenzidineN,N'-Diacetylbenzidine613-35-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
2,4-Diaminoanisole2,4-Diaminoanisole615-05-4 substancecancer 30 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-10-01
2,4-Diaminoanisole sulfate2,4-Diaminoanisole sulfate39156-41-7 substancecancer 50 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
2,4-Diamino-6-chloro-s-triazine (DACT)2,4-Diamino-6-chloro-s-triazine (DACT)3397-62-4 substancedevelopmental, female 100 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-07-15
4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline)4,4'-Diaminodiphenyl ether (4,4'-Oxydianiline)101-80-4 substancecancer 5 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
2,4-Diaminotoluene2,4-Diaminotoluene95-80-7 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Diaminotoluene (mixed) Delisted November, 20 2015 [Click here for the basis for delisting]Diaminotoluene (mixed) Delisted November, 20 2015 [Click here for the basis for delisting] othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01 | CAS column: "---"
DiazepamDiazepam439-14-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
DiazoaminobenzeneDiazoaminobenzene136-35-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2005-05-20
DiazoxideDiazoxide364-98-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
Dibenz[a,h]acridineDibenz[a,h]acridine226-36-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenz[a,j]acridineDibenz[a,j]acridine224-42-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
DibenzanthracenesDibenzanthracenes othercancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26 | CAS column: "---"
Dibenz[a,c]anthraceneDibenz[a,c]anthracene215-58-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
Dibenz[a,h]anthraceneDibenz[a,h]anthracene53-70-3 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenz[a,j]anthraceneDibenz[a,j]anthracene224-41-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2014-12-26
7H-Dibenzo[c,g]carbazole7H-Dibenzo[c,g]carbazole194-59-2 substancecancer 0.0030 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenzo[a,e]pyreneDibenzo[a,e]pyrene192-65-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenzo[a,h]pyreneDibenzo[a,h]pyrene189-64-0 substancecancer 0.0054 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenzo[a,i]pyreneDibenzo[a,i]pyrene189-55-9 substancecancer 0.0050 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibenzo[a,l]pyreneDibenzo[a,l]pyrene191-30-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dibromoacetic acidDibromoacetic acid631-64-1 substancecancer 2.8 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2008-06-17
DibromoacetonitrileDibromoacetonitrile3252-43-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-05-03
1,2-Dibromo-3-chloropropane (DBCP)1,2-Dibromo-3-chloropropane (DBCP)96-12-8 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
1,2-Dibromo-3-chloropropane (DBCP) [Basis for listing changed effective November 22, 2013]1,2-Dibromo-3-chloropropane (DBCP) [Basis for listing changed effective November 22, 2013]96-12-8 substancemale 3.1 (oral) 4.3 (inhalation) µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-02-27
2,3-Dibromo-1-propanol2,3-Dibromo-1-propanol96-13-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1994-10-01
Dichloroacetic acidDichloroacetic acid79-43-6 substancecancer 17 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
Dichloroacetic acidDichloroacetic acid79-43-6 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2009-08-07
p-Dichlorobenzenep-Dichlorobenzene106-46-7 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
3,3'-Dichlorobenzidine3,3'-Dichlorobenzidine91-94-1 substancecancer 0.6 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
3,3'-Dichlorobenzidine dihydrochloride3,3'-Dichlorobenzidine dihydrochloride612-83-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
1,1-Dichloro-2,2-bis(p-chloropheny)ethylene (DDE)1,1-Dichloro-2,2-bis(p-chloropheny)ethylene (DDE)72-55-9 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-03-30
1,4-Dichloro-2-butene1,4-Dichloro-2-butene764-41-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
3,3'-Dichloro-4,4'-diamino-diphenyl ether3,3'-Dichloro-4,4'-diamino-diphenyl ether28434-86-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
1,1-Dichloroethane1,1-Dichloroethane75-34-3 substancecancer 100 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Dichloromethane (Methylene chloride)Dichloromethane (Methylene chloride)75-09-2 substancecancer 50 200 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-04-01
1,4-Dichloro-2-nitrobenzene1,4-Dichloro-2-nitrobenzene89-61-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
2,4-Dichloro-1-nitrobenzene2,4-Dichloro-1-nitrobenzene611-06-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
DichloropheneDichlorophene97-23-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-04-27
DichlorphenamideDichlorphenamide120-97-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
1,2-Dichloropropane1,2-Dichloropropane78-87-5 substancecancer 9.7 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
1,3-Dichloro-2-propanol (1,3-DCP)1,3-Dichloro-2-propanol (1,3-DCP)96-23-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2010-10-08
1,3-Dichloropropene1,3-Dichloropropene542-75-6 substancecancer 3.7 (oral and inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Diclofop-methylDiclofop-methyl51338-27-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2010-04-06
Diclofop methylDiclofop methyl51338-27-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-05
DicumarolDicumarol66-76-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
DieldrinDieldrin60-57-1 substancecancer 0.04 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01
DienestrolDienestrol84-17-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1990-01-01 | Delisted: January 4, 2013 until 2013-01-04
DiepoxybutaneDiepoxybutane1464-53-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Diesel engine exhaustDiesel engine exhaust othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01 | CAS column: "---"
DiethanolamineDiethanolamine111-42-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-06-22
Di(2-ethylhexyl)phthalate (DEHP)Di(2-ethylhexyl)phthalate (DEHP)117-81-7 substancecancer 310 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Di(2-ethylhexyl)phthalate (DEHP)Di(2-ethylhexyl)phthalate (DEHP)117-81-7 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2003-10-24
AdultAdult otherdevelopmental, male 4200 (intravenous) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
Infant boys, age 29 days to 24 monthsInfant boys, age 29 days to 24 months otherdevelopmental, male 600 (intravenous) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
Neonatal infant boys, age 0 to 28 daysNeonatal infant boys, age 0 to 28 days otherdevelopmental, male 210 (intravenous) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
AdultAdult otherdevelopmental, male 410 (oral) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
Infant boys, age 29 days to 24 monthsInfant boys, age 29 days to 24 months otherdevelopmental, male 58 (oral) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
Neonatal infant boys, age 0 to 28 daysNeonatal infant boys, age 0 to 28 days otherdevelopmental, male 20 (oral) µg/day (NSRL or MADL) Sub entry under "Di(2-ethylhexyl)phthalate (DEHP)" giving a safe harbor level for this member or population; type of toxicity, listing mechanism and date listed are those of the parent entry | b: Levels for male children and adolescents were calculated by application of the default bodyweights specified in Section 25703(a)(8) to the procedure specified in Sections 25801 and 25803
1,2-Diethylhydrazine1,2-Diethylhydrazine1615-80-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Diethylstilbestrol (DES)Diethylstilbestrol (DES)56-53-1 substancecancer 0.002 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1987-02-27
Diethylstilbestrol (DES)Diethylstilbestrol (DES)56-53-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
Diethyl sulfateDiethyl sulfate64-67-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
DiflunisalDiflunisal22494-42-4 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Diglycidyl etherDiglycidyl ether2238-07-5 substancemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: April 4, 2014 until 2014-04-04
Diglycidyl resorcinol ether (DGRE)Diglycidyl resorcinol ether (DGRE)101-90-6 substancecancer 0.4 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Dihydroergotamine mesylateDihydroergotamine mesylate6190-39-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-05-01
DihydrosafroleDihydrosafrole94-58-6 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Di-isodecyl phthalate (DIDP)Di-isodecyl phthalate (DIDP)68515-49-1/ 26761-40-0 substancedevelopmental 2200 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2007-04-20
Diisononyl phthalate (DINP)Diisononyl phthalate (DINP) othercancer 146 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2013-12-20 | CAS column: "---"
Diisopropyl sulfateDiisopropyl sulfate2973-10-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1993-04-01
Diltiazem hydrochlorideDiltiazem hydrochloride33286-22-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
3,3'-Dimethoxybenzidine (o-Dianisidine)3,3'-Dimethoxybenzidine (o-Dianisidine)119-90-4 substancecancer 0.15 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
3,3'-Dimethoxybenzidine dihydrochloride3,3'-Dimethoxybenzidine dihydrochloride20325-40-0 substancecancer 0.19 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
3,3'-Dimethoxybenzidine-based dyes metabolized to 3,3'-dimethoxybenzidine3,3'-Dimethoxybenzidine-based dyes metabolized to 3,3'-dimethoxybenzidine othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-06-11 | CAS column: "---"
N,N-DimethylacetamideN,N-Dimethylacetamide127-19-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2019-09-13
N,N-Dimethylacetamide [Click here for the basis for addition of male reproductive endpoint, effective December 20, 2013]N,N-Dimethylacetamide [Click here for the basis for addition of male reproductive endpoint, effective December 20, 2013]127-19-5 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2010-05-21
4-Dimethylaminoazobenzene4-Dimethylaminoazobenzene60-11-7 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
trans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazoletrans-2-[(Dimethylamino)methylimino]-5-[2-(5-nitro-2-furyl)vinyl]-1,3,4-oxadiazole55738-54-0 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
7,12-Dimethylbenz(a)anthracene7,12-Dimethylbenz(a)anthracene57-97-6 substancecancer 0.003 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
3,3'-Dimethylbenzidine (ortho-Tolidine)3,3'-Dimethylbenzidine (ortho-Tolidine)119-93-7 substancecancer 0.044 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
3,3'-Dimethylbenzidine-based dyes metabolized to 3,3'-dimethylbenzidine3,3'-Dimethylbenzidine-based dyes metabolized to 3,3'-dimethylbenzidine othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-06-11 | CAS column: "---"
3,3'-Dimethylbenzidine dihydrochloride3,3'-Dimethylbenzidine dihydrochloride612-82-8 substancecancer 0.059 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1992-04-01
Dimethylcarbamoyl chlorideDimethylcarbamoyl chloride79-44-7 substancecancer 0.05 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N,N-DimethylformamideN,N-Dimethylformamide68-12-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2017-10-27
1,1-Dimethylhydrazine (UDMH)1,1-Dimethylhydrazine (UDMH)57-14-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 1989-10-01
1,2-Dimethylhydrazine1,2-Dimethylhydrazine540-73-8 substancecancer 0.001 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Dimethyl hydrogen phosphiteDimethyl hydrogen phosphite868-85-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-08-11
2,6-Dimethyl-N-nitrosomorpholine (DMNM)2,6-Dimethyl-N-nitrosomorpholine (DMNM)1456-28-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2013-02-08
Dimethyl sulfateDimethyl sulfate77-78-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
N,N-Dimethyl-p-toluidineN,N-Dimethyl-p-toluidine99-97-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2014-05-02
DimethylvinylchlorideDimethylvinylchloride513-37-1 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Di-n-butyl phthalate (DBP)Di-n-butyl phthalate (DBP)84-74-2 substancedevelopmental, female, male 8.7 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-12-02
Di-n-hexyl phthalate (DnHP)Di-n-hexyl phthalate (DnHP)84-75-3 substancefemale, male 2200 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2005-12-02
m-Dinitrobenzenem-Dinitrobenzene99-65-0 substancemale 38 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
o-Dinitrobenzeneo-Dinitrobenzene528-29-0 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
p-Dinitrobenzenep-Dinitrobenzene100-25-4 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
3,7-Dinitrofluoranthene3,7-Dinitrofluoranthene105735-71-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
3,9-Dinitrofluoranthene3,9-Dinitrofluoranthene22506-53-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1997-08-26
1,3-Dinitropyrene1,3-Dinitropyrene75321-20-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2012-11-02
1,6-Dinitropyrene1,6-Dinitropyrene42397-64-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
1,8-Dinitropyrene1,8-Dinitropyrene42397-65-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
2,4-Dinitrotoluene2,4-Dinitrotoluene121-14-2 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01
2,4-Dinitrotoluene2,4-Dinitrotoluene121-14-2 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
2,6-Dinitrotoluene2,6-Dinitrotoluene606-20-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1995-07-01
2,6-Dinitrotoluene2,6-Dinitrotoluene606-20-2 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
Dinitrotoluene (technical grade)Dinitrotoluene (technical grade) otherfemale, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20 | CAS column: "---"
Dinitrotoluene mixture, 2,4-/2,6-Dinitrotoluene mixture, 2,4-/2,6- groupcancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01 | CAS column: "---"
DinocapDinocap39300-45-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
DinosebDinoseb88-85-7 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1989-01-01
Di-n-propyl isocinchomeronate (MGK Repellent 326)Di-n-propyl isocinchomeronate (MGK Repellent 326)136-45-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-05-01
1,4-Dioxane1,4-Dioxane123-91-1 substancecancer 30 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Diphenylhydantoin (Phenytoin)Diphenylhydantoin (Phenytoin)57-41-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Diphenylhydantoin (Phenytoin)Diphenylhydantoin (Phenytoin)57-41-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Diphenylhydantoin (Phenytoin), sodium saltDiphenylhydantoin (Phenytoin), sodium salt630-93-3 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Direct Black 38 (technical grade)Direct Black 38 (technical grade)1937-37-7 substancecancer 0.09 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Direct Blue 6 (technical grade)Direct Blue 6 (technical grade)2602-46-2 substancecancer 0.09 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Direct Brown 95 (technical grade)Direct Brown 95 (technical grade)16071-86-6 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
Disodium cyanodithioimidocarbonateDisodium cyanodithioimidocarbonate138-93-2 substancedevelopmental 56 (oral) 170 (oral) as 32% pesticidal formulation µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-30
Disperse Blue 1Disperse Blue 12475-45-8 substancecancer 200 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01
DiuronDiuron330-54-1 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2002-05-31
Doxorubicin hydrochloride (Adriamycin)Doxorubicin hydrochloride (Adriamycin)25316-40-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Doxorubicin hydrochloride (Adriamycin)Doxorubicin hydrochloride (Adriamycin)25316-40-9 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
Doxycycline (internal use)Doxycycline (internal use)564-25-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Doxycycline calcium (internal use)Doxycycline calcium (internal use)94088-85-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-01-01
Doxycycline hyclate (internal use)Doxycycline hyclate (internal use)24390-14-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
Doxycycline monohydrate (internal use)Doxycycline monohydrate (internal use)17086-28-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1991-10-01
2,4-DP (dichloroprop)2,4-DP (dichloroprop)120-36-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-04-27 | Delisted: January 25, 2002 until 2002-01-25
Emissions from combustion of coalEmissions from combustion of coal othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2013-08-07 | CAS column: "---"
Emissions from high-temperature unrefined rapeseed oilEmissions from high-temperature unrefined rapeseed oil othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2014-01-03 | CAS column: "---"
EndrinEndrin72-20-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Environmental tobacco smoke (ETS)Environmental tobacco smoke (ETS) otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2006-06-09 | CAS column: "---"
EpichlorohydrinEpichlorohydrin106-89-8 substancecancer 9 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
EpichlorohydrinEpichlorohydrin106-89-8 substancemale µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1996-09-01
EpoxiconazoleEpoxiconazole135319-73-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2011-04-15
Ergotamine tartrateErgotamine tartrate379-79-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
ErioniteErionite12510-42-8; 66733-21-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-10-01
Estradiol 17BEstradiol 17B50-28-2 substancecancer 0.02 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
EstragoleEstragole140-67-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1999-10-29
Estrogens, steroidalEstrogens, steroidal othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2005-08-19 | CAS column: "---"
Estrogen-progestogen (combined) used as menopausal therapyEstrogen-progestogen (combined) used as menopausal therapy othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-11-04 | CAS column: "---"
EstroneEstrone53-16-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
EstropipateEstropipate7280-37-7 substancecancer, developmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
EthinylestradiolEthinylestradiol57-63-6 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
EthionamideEthionamide536-33-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
EthopropEthoprop13194-48-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2001-02-27
Ethyl acrylateEthyl acrylate140-88-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
Ethyl alcohol in alcoholic beveragesEthyl alcohol in alcoholic beverages otherdevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01 | CAS column: "---"
EthylbenzeneEthylbenzene100-41-4 substancecancer 54 (inhalation) 41 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2004-06-11
Ethyl-tert-butyl etherEthyl-tert-butyl ether637-92-3 substancemale µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-12-18 | Delisted: December 13, 2013 until 2013-12-13
Ethyl dipropylthiocarbamateEthyl dipropylthiocarbamate759-94-4 substancedevelopmental 700 (oral and inhalation) 6700 (dermal) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-04-27
Ethyl-4,4'-dichlorobenzilateEthyl-4,4'-dichlorobenzilate510-15-6 substancecancer 7 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Ethylene dibromideEthylene dibromide106-93-4 substancecancer 0.2 (oral) 3 (inhalation) µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
Ethylene dibromideEthylene dibromide106-93-4 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-05-15
Ethylene dichloride (1,2-Dichloroethane)Ethylene dichloride (1,2-Dichloroethane)107-06-2 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-10-01
Ethylene glycol (ingested)Ethylene glycol (ingested)107-21-1 substancedevelopmental 8700 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2015-06-19
Ethylene glycol monoethyl etherEthylene glycol monoethyl ether110-80-5 substancedevelopmental, male 750 (oral) 960 (inhalation) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Ethylene glycol monoethyl ether acetateEthylene glycol monoethyl ether acetate111-15-9 substancedevelopmental, male 1100 (oral) 1400 (inhalation) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1993-01-01
Ethylene glycol monomethyl etherEthylene glycol monomethyl ether109-86-4 substancedevelopmental, male 63 (oral) µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Ethylene glycol monomethyl ether acetateEthylene glycol monomethyl ether acetate110-49-6 substancedevelopmental, male 98 (oral) µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1993-01-01
Ethyleneimine (Aziridine)Ethyleneimine (Aziridine)151-56-4 substancecancer 0.01 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Ethylene oxideEthylene oxide75-21-8 substancecancer 2 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-07-01
Ethylene oxide [Basis for listing changed effective November 22, 2013]Ethylene oxide [Basis for listing changed effective November 22, 2013]75-21-8 substancefemale 20 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1987-02-27
Ethylene oxide [Basis for listing changed effective November 22, 2013]Ethylene oxide [Basis for listing changed effective November 22, 2013]75-21-8 substancedevelopmental, male 20 µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2009-08-07
Ethylene thioureaEthylene thiourea96-45-7 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1988-01-01
Ethylene thioureaEthylene thiourea96-45-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1993-01-01
2-Ethylhexanoic acid2-Ethylhexanoic acid149-57-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2009-08-07 | Delisted: December 13, 2013 until 2013-12-13
2-Ethylhexyl acrylate2-Ethylhexyl acrylate103-11-7 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2021-12-17
Ethyl methanesulfonateEthyl methanesulfonate62-50-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
EtodolacEtodolac41340-25-4 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
EtoposideEtoposide33419-42-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-11-04
EtoposideEtoposide33419-42-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Etoposide in combination with cisplatin and bleomycinEtoposide in combination with cisplatin and bleomycin othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2011-11-04 | CAS column: "---"
EtretinateEtretinate54350-48-0 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1987-07-01
Fenoxaprop ethylFenoxaprop ethyl66441-23-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-03-26
FenoxycarbFenoxycarb72490-01-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2000-06-02
FilgrastimFilgrastim121181-53-1 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2001-02-27
Fluazifop butylFluazifop butyl69806-50-4 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
FlunisolideFlunisolide3385-03-3 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
FluorouracilFluorouracil51-21-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Fluoro-edenite fibrous amphiboleFluoro-edenite fibrous amphibole othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-11-17 | CAS column: "---"
FluoxymesteroneFluoxymesterone76-43-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-04-01
Flurazepam hydrochlorideFlurazepam hydrochloride1172-18-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1992-10-01
FlurbiprofenFlurbiprofen5104-49-4 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
FlutamideFlutamide13311-84-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Fluticasone propionateFluticasone propionate80474-14-2 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1998-05-15
FluvalinateFluvalinate69409-94-5 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1998-11-06
FolpetFolpet133-07-3 substancecancer 200 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-01-01
Formaldehyde (gas)Formaldehyde (gas)50-00-0 substancecancer 40 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole2-(2-Formylhydrazino)-4-(5-nitro-2-furyl)thiazole3570-75-0 substancecancer 0.3 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
Fumonisin B1Fumonisin B1116355-83-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2003-11-14
FuranFuran110-00-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1993-10-01
FurazolidoneFurazolidone67-45-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Furfuryl alcoholFurfuryl alcohol98-00-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 2016-09-30
FurmecycloxFurmecyclox60568-05-0 substancecancer 20 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Fusarin CFusarin C79748-81-5 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1995-07-01
Gallium arsenideGallium arsenide1303-00-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2008-08-01
GanciclovirGanciclovir82410-32-0 substancecancer, developmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
Ganciclovir sodiumGanciclovir sodium107910-75-8 substancedevelopmental, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
Gasoline engine exhaust (condensates/extracts)Gasoline engine exhaust (condensates/extracts) othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-10-01 | CAS column: "---"
GemfibrozilGemfibrozil25812-30-0 substancecancer µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 2000-12-22
GemfibrozilGemfibrozil25812-30-0 substancefemale, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
Gentian violet (Crystal violet)Gentian violet (Crystal violet)548-62-9 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 2018-11-23
Glass wool fibers (inhalable and biopersistent)Glass wool fibers (inhalable and biopersistent) othercancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01 | CAS column: "---"
Glu-P-1 (2-Amino-6-methyldipyrido[1,2- a:3',2'-d]imidazole)Glu-P-1 (2-Amino-6-methyldipyrido[1,2- a:3',2'-d]imidazole)67730-11-4 substancecancer 0.1 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)Glu-P-2 (2-Aminodipyrido[1,2-a:3',2'-d]imidazole)67730-10-3 substancecancer 0.5 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
GlycidaldehydeGlycidaldehyde765-34-4 substancecancer µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
GlycidolGlycidol556-52-5 substancecancer 0.54 µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-07-01
Glycidyl methacrylateGlycidyl methacrylate106-91-2 substancecancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2023-01-27
GlyphosateGlyphosate1071-83-6 substancecancer 1100 µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2017-07-07
Goldenseal root powderGoldenseal root powder othercancer µg/day (NSRL or MADL) Listing mechanism: LC; Date listed: 2015-12-04 | CAS column: "---"
Goserelin acetateGoserelin acetate65807-02-5 substancedevelopmental, female, male µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1997-08-26
GriseofulvinGriseofulvin126-07-8 substancecancer µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1990-01-01
Gyromitrin (Acetaldehyde methylformylhydrazone)Gyromitrin (Acetaldehyde methylformylhydrazone)16568-02-8 substancecancer 0.07 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-01-01
HalazepamHalazepam23092-17-3 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1990-07-01
Halobetasol propionateHalobetasol propionate66852-54-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-08-20
HaloperidolHaloperidol52-86-8 substancedevelopmental, female µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1999-01-29
HalothaneHalothane151-67-7 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: FR; Date listed: 1996-09-01
HC Blue 1HC Blue 12784-94-3 substancecancer 10 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1989-07-01
HeptachlorHeptachlor76-44-8 substancecancer 0.2 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01
HeptachlorHeptachlor76-44-8 substancedevelopmental µg/day (NSRL or MADL) Listing mechanism: AB; Date listed: 1999-08-20
Heptachlor epoxideHeptachlor epoxide1024-57-3 substancecancer 0.08 µg/day (NSRL or MADL) Listing mechanism: SQE; Date listed: 1988-07-01

Official source

Entries are copied exactly as published. Not legal advice; always check the official text.

2,437 SDSs. None left to chase.

NextSDS processes all 16 sections of every safety data sheet you receive and flags each product with a substance on Suggested substance list.

Get started todaySee how NextSDS works